Who invested in Cloverleaf Bio

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$33Mraised across 1 round since 2026, from 2 sources

Latest round: Seed, $33MSept 2026
Led by: 4BIO Capital
Investors: 5 (1 led)

See who backed them

The rounds

Sept 2026
Seed$33M
Reported by 4BIO Capital and 1 otherSEC filing: $15M sold

Everyone who backed them

4BIO CapitalVC firm1round, led 1

Draper AssociatesVC firm1round

Boehringer Ingelheim Venture FundCorporate VC1round

Mission BioCapitalVC firm1round

American Cancer Society BrightEdgeVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Cloverleaf Bio

Who invested in Cloverleaf Bio?

Cloverleaf Bio's investors include 4BIO Capital, Draper Associates, Boehringer Ingelheim Venture Fund, Mission BioCapital and American Cancer Society BrightEdge. 4BIO Capital led its latest round.

How much has Cloverleaf Bio raised?

Cloverleaf Bio has raised $33M across 1 round since 2026.

When did Cloverleaf Bio last raise?

Cloverleaf Bio's most recent round was a Seed of $33M in Sept 2026, led by 4BIO Capital.

What was Cloverleaf Bio's biggest round?

Its most recent round, $33M in Sept 2026, is also its largest on record.

Who backed Cloverleaf Bio first?

Cloverleaf Bio's first round on record, in Sept 2026, was backed by 4BIO Capital, Draper Associates and Boehringer Ingelheim Venture Fund and 2 others.